Sanofi Pipeline

Our determination to find answers for patients and their families motivates us to pursue medicines and vaccines with the greatest potential to improve lives and protect public health. With a strong focus on difficult-to-treat diseases and immunization, our R&D pipeline includes clinical-stage projects, of which are in phase 3 or have been submitted to regulatory authorities for approval. Some of these are new molecular entities while others are existing products with potential new indications, or different formulations. All of them are made possible by people who volunteer to participate in a clinical trial.

Phase 1

Phase 2

Phase 3

Registration

Phase 1

Phase 2

Phase 3

Registration

Therapeutic Areas open
All phases open
All open
Search

projects of

Therapeutic Area

Phase

Name

Description

Indication

Program Updates

The following changes occurred in our R&D programs.

Updated on July 28, 2023

Therapeutic Area

Phase

Name

Description

Additional Details